Thalassaemia continues to impose a significant health burden across India, particularly in regions with a high carrier rate. What makes this condition especially concerning is that it is largely preventable. Individuals carrying the thalassaemia trait are usually healthy and unaware of their status, but when two carriers marry, there is a high risk of having a child with thalassaemia major—a severe, lifelong disorder requiring regular blood transfusions and medical care.

Understanding the Genetic Risk

Thalassaemia is an inherited blood disorder passed from parents to children through genes. When both partners are carriers, each pregnancy carries a 25% chance of producing an affected child. This risk remains the same with every pregnancy, making awareness before marriage critically important. Without screening, couples often discover this only after the birth of an affected child, when the emotional and medical challenges have already begun.

The Burden on Families and Healthcare Systems

Children with thalassaemia major require lifelong treatment, including frequent blood transfusions and iron chelation therapy to prevent complications. This not only places a heavy financial burden on families but also leads to emotional stress and reduced quality of life. Over time, the cumulative impact on healthcare resources becomes substantial, highlighting the importance of prevention over long-term management.

Why Premarital Screening Matters

Premarital screening provides an opportunity to identify carriers before marriage and make informed decisions. A simple blood test can determine carrier status. If both individuals are found to be carriers, they can seek genetic counselling to understand the risks and available options. This approach empowers couples with knowledge and helps prevent the birth of affected children.

Breaking Social Barriers and Stigma

One of the major challenges in implementing widespread screening is social stigma and a lack of open discussion about genetic conditions. Many families hesitate to undergo testing due to fear of discrimination or misunderstanding. However, thalassaemia carrier status is not a disease and does not affect an individual’s health or abilities. Normalising screening as a routine health check can help overcome these barriers.

The Role of Awareness and Education

Public awareness remains limited, with many people unaware that such a simple test can prevent a serious condition. Educational institutions, community programs, and healthcare providers have a crucial role in spreading awareness. Encouraging screening at a younger age, even before marriage is considered, can significantly improve acceptance and participation.

Learning from Successful Models

Several countries and regions have successfully reduced the incidence of thalassaemia through mandatory or strongly encouraged premarital screening programs. These models demonstrate that with proper policy support and public cooperation, it is possible to control the spread of the disorder and reduce its long-term impact on society.

A Step Towards Healthier Generations

Making premarital screening a social priority is not about restricting choices but about enabling informed decisions. It allows couples to plan their future with clarity and responsibility. Preventing a single case of thalassaemia major spares a child from lifelong medical dependency and significantly reduces emotional and financial strain on families.

A Collective Responsibility

Addressing thalassaemia requires a shift in perspective—from treatment to prevention. Healthcare systems, policymakers, and communities must work together to promote routine screening as a norm rather than an exception. Integrating screening into standard premarital or early adult health check-ups can make a meaningful difference.

The Way Forward

Premarital screening for thalassaemia is a simple, effective, and impactful intervention. Prioritising it at a societal level can help break the cycle of transmission and ensure healthier future generations. Awareness, acceptance, and timely action remain the key to achieving this goal.

About the author- Dr. Sonal Paul, Consultant – Hematologist & Bone Marrow Transplant Physician, Narayana Hospital, Howrah